- Home
- BHVN vs TGLS Comparison
BHVN vs TGLS Comparison
Compare BHVN & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- TGLS
- Stock Information
- Founded
- BHVN 2013
- TGLS 1984
- Country
- BHVN United States
- TGLS Colombia
- Employees
- BHVN N/A
- TGLS N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- TGLS Electronic Components
- Sector
- BHVN Health Care
- TGLS Consumer Discretionary
- Exchange
- BHVN Nasdaq
- TGLS Nasdaq
- Market Cap
- BHVN 3.6B
- TGLS 3.7B
- IPO Year
- BHVN 2017
- TGLS 2012
- Fundamental
- Price
- BHVN $36.17
- TGLS $79.91
- Analyst Decision
- BHVN Strong Buy
- TGLS Buy
- Analyst Count
- BHVN 13
- TGLS 5
- Target Price
- BHVN $63.00
- TGLS $75.40
- AVG Volume (30 Days)
- BHVN 1.1M
- TGLS 244.3K
- Earning Date
- BHVN 11-12-2024
- TGLS 11-07-2024
- Dividend Yield
- BHVN N/A
- TGLS 0.55%
- EPS Growth
- BHVN N/A
- TGLS N/A
- EPS
- BHVN N/A
- TGLS 3.20
- Revenue
- BHVN N/A
- TGLS $845,211,000.00
- Revenue This Year
- BHVN N/A
- TGLS $8.94
- Revenue Next Year
- BHVN $197.10
- TGLS $10.72
- P/E Ratio
- BHVN N/A
- TGLS $25.04
- Revenue Growth
- BHVN N/A
- TGLS N/A
- 52 Week Low
- BHVN $26.80
- TGLS $40.94
- 52 Week High
- BHVN $62.21
- TGLS $86.08
- Technical
- Relative Strength Index (RSI)
- BHVN 33.02
- TGLS 50.79
- Support Level
- BHVN $36.70
- TGLS $78.02
- Resistance Level
- BHVN $42.13
- TGLS $85.83
- Average True Range (ATR)
- BHVN 2.84
- TGLS 2.57
- MACD
- BHVN -0.67
- TGLS -0.75
- Stochastic Oscillator
- BHVN 13.18
- TGLS 23.48
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About TGLS Tecnoglass Inc.
Tecnoglass Inc designs, manufactures, distributes, and markets architectural glass and windows. The company's products portfolio includes tempered, laminated, insulating and Solar Control Low-E glass. Its products are installed at hotels, residential buildings, commercial and corporate centers, airports and hospitals as floating facades, curtain walls, windows, doors, handrails, interior and dividers. Its majority of revenue is derived from the sale and installation of architectural glass and windows in the United States.